Recruiting PRE-I-SPY Phase I/Ib Oncology Platform Program NCT05868226 Conditions Breast Diseases, Breast Neoplasms, ER Positive Breast Cancer, +29 more Locations The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center — Birmingham, Alabama, United States Moffitt Cancer Center — Tampa, Florida, United States The University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois, United States UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital — New Lenox, Illinois, United States View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer NCT06733233 Conditions Breast Cancer, Estrogen Receptor-Positive, Breast Diseases, Breast Neoplasms, +5 more Locations Not specified View Trial Details
